Hypothesis

Progressive presbycusis does not merely reflect peripheral damage; it actively remodels the gut microenvironment through a vagal‑mediated anti‑inflammatory pathway. We hypothesize that chronic auditory deprivation reduces afferent signaling to the nucleus tractus solitarius (NTS), diminishing efferent vagal output to the gut. This loss of cholinergic tone lowers acetylcholine release in the intestinal mucosa, decreasing expression of tight‑junction proteins (claudin‑1, occludin) and increasing intestinal permeability. The resulting translocation of microbial lipopolysaccharide (LPS) fuels systemic inflammation, which re‑enters the cochlea via a compromised blood‑labyrinth barrier, exacerbating stria vascularis atrophy and spiral ganglion neuron (SGN) loss. Thus, hearing loss initiates a vicious gut‑cochlea cycle that accelerates age‑related sensory decline.

Mechanistic Insight

Recent work shows that gut‑derived metabolites can set the brain's homeostatic baseline (see seed idea). We extend this by proposing that the direction of influence is context‑dependent: when sensory input wanes, the brain's autonomic output to the gut wanes in parallel, flipping the axis from bottom‑up to top‑down loss of regulation. The cholinergic anti‑inflammatory pathway, mediated by α7‑nicotinic acetylcholine receptors on macrophages, is a well‑established link between vagal activity and gut barrier integrity (Tracey, 2020). Auditory‑driven NTS activation is known to sustain vagal efferent firing ([Zheng et al., 2021](https://doi.

The hypothesis is that age‑related gut barrier disruption releases bacterial succinate and other DAMPs that activate the succinate receptor SUCNR1 on lamina propria macrophages, amplifying NLRP3 inflammasome signaling and IL‑1β production. This IL‑1β then acts directly on circulating CD8+ T cells, driving STAT3‑dependent upregulation of the transcription factor TOX and consequent expression of exhaustion markers PD‑1, TIM‑3 and LAG‑3. In other words, gut‑derived succinate provides a specific molecular link that converts systemic inflammaging into irreversible T‑cell dysfunction.

Testable predictions:

1. Aged mice will show elevated luminal succinate levels, increased SUCNR1 expression on gut macrophages, and higher caspase‑1 cleavage compared with young controls.
2. Oral administration of a non‑absorbable SUCNR1 antagonist (or succinate‑scavenging probiotic) will reduce NLRP3 activation in the gut lamina propria, lower systemic IL‑1β, and decrease the frequency of PD‑1⁺TIM‑3⁺LAG‑3⁺ CD8+ T cells in blood and spleen.
3. Adoptive transfer of SUCNR1‑deficient macrophages into aged recipients will blunt the rise in T‑cell exhaustion markers despite an aged microbiome.
4. Blocking IL‑1R on T cells (using anakinra) will rescue proliferative capacity and cytokine production (IFN‑γ, IL‑2) of CD8+ T cells from aged mice, even when gut succinate remains high.

Experimental approach:

• Measure fecal and portal vein succinate by LC‑MS in young (3 mo) and aged (24 mo) C57BL/6 mice.
• Flow cytometry of intestinal macrophages for SUCNR1, NLRP3, cleaved caspase‑1, and intracellular

Hypothesis

Amyloid aggregates are not merely toxic waste; they function as intracellular sinks that sequester redox‑active metal ions, thereby lowering the labile iron pool and attenuating Fenton‑driven ROS production.

Mechanistic basis

• The cross‑β spine of amyloid fibrils exposes side‑chain carboxylates and imidazole groups that bind Fe²⁺/Fe³⁺ with high affinity (see structural analyses of fibrillar surfaces 1).

• Binding reduces the concentration of catalytically active iron, limiting hydroxyl radical generation via the Fenton reaction.

• This sequestration is thermodynamically favored because the aggregated state offers a multivalent, low‑entropy environment for metal coordination, aligning with the observation that aggregates represent the proteome’s last attempt at order 2.

Testable predictions

1. Cells engineered to overexpress an amyloid‑prone protein (e.g., mutant huntingtin exon‑1) will display a measurable decrease in labile iron under oxidative challenge compared with controls; iron chelators will not further lower ROS in these cells.

Hypothesis

Individuals who adjust their consumer sleep and glucose tracker thresholds based on real‑time HRV‑derived autonomic balance will show stronger associations between self‑tracked metrics and hard cardiometabolic outcomes than users who rely on manufacturer‑default thresholds.

Mechanistic Rationale

HRV reflects vagal tone, which directly modulates hepatic glucose production and sleep‑stage transitions via the central autonomic network.5 When vagal activity is high, hepatic insulin sensitivity improves and slow‑wave sleep increases; low vagal signaling shifts metabolism toward gluconeogenesis and fragments sleep.11 Consumer devices, however, apply fixed cut‑offs (e.g., 7 h sleep, 100 mg/dL post‑prandial glucose) that ignore this physiological state, producing mis‑aligned feedback and weakening the link between tracked data and health risk.4 By dynamically scaling sleep‑duration and glucose‑excursion targets according to an individual’s HRV‑derived vagal index (e.g., SDNN), we align device output with the underlying autonomic milieu, restoring the physiological signal that predicts CVD.2

Testable Predictions

• Prediction 1: The slope linking HRV‑adjusted sleep duration to incident CVD events will be significantly steeper (more negative) than the slope using raw sleep duration.
• Prediction 2: HRV‑adjusted post‑prandial glucose excursions will predict 6‑month changes in H

Hypothesis

Intermittent dasatinib + quercetin (D+Q) treatment does more than clear senescent cells; it reprograms the tissue niche via sustained alteration of extracellular vesicle (EV) cargo that suppresses mTOR activity in neighboring cells long after drug washout. In contrast, rapamycin’s lifespan extension depends on continuous mTORC1 inhibition within each cell and rapidly reverses upon cessation because it does not remodel the niche.

Mechanistic basis

1. Senolytic‑EV shift – D+Q‑induced apoptosis of senescent cells releases EVs enriched in anti‑inflammatory miRNAs (e.g., miR‑146a, miR‑21) and depleted of SASP‑promoting cargos, as shown in lung and intestine models [2][5]. These EVs are taken up by stem/progenitor cells, where they activate AMPK and inhibit mTORC1 signaling through PTEN up‑regulation, creating a cell‑autonomous low‑mTOR state that persists because the EVs remain in the extracellular matrix for weeks [6].
2. Epigenetic niche memory – The reduced SASP lowers NF‑κB signaling in stromal cells, leading to decreased H3K27ac at promoters of mTOR‑activating genes (e.g., Rheb, RagA). This chromatin state is maintained through cycles of cell division, effectively “locking” a low‑mTOR transcriptional program in the niche [3].
3. Rapamycin lacks this loop – Rapamycin inhibits mTORC1 directly but does not alter EV composition or SASP; upon washout, mTORC1 reactivates because the upstream inhibitory signals (AMPK, PTEN) are not reinforced by niche‑derived cues.

Testable predictions

• Prediction 1: In aged mice receiving intermittent D

Hypothesis

Humanin and other mitochondrial-derived peptides (MDPs) act as molecular switches that preferentially engage receptor-mediated mitophagy (BNIP3L/NIX, FUNDC1) while suppressing the PINK1-Parkin damage-sensing axis, thereby determining which mitochondrial subpopulations are retained during cellular stress.

Mechanistic Rationale

Recent work shows that in cardiac progenitor cells mitophagy is driven chiefly by BNIP3L/NIX and FUNDC1, targeting non-depolarized mitochondria for preemptive remodeling [1]. Humanin is known to promote survival via FPRL1/2 and CNTFR/gp130 receptors, inhibiting Bax/tBid and activating downstream signaling cascades [2]. We propose that Humanin-bound FPRL1 triggers a Gαi‑mediated reduction in cAMP, activating protein kinase A (PKA) which phosphorylates Drp1 at the inhibitory Ser637 site. Concurrently, Humanin may expose a cryptic LC3-interacting region (LIR) within its sequence, allowing direct interaction with LC3 on mitochondria earmarked for BNIP3L/NIX or FUNDC1 recruitment. This dual action would (1) curb excessive fission driven by Drp1-Ser616 phosphorylation and (2) scaffold autophagosome formation preferentially at receptor-rich mitochondrial domains, shifting the mitophagy hierarchy toward programmed remodeling rather than damage‑induced clearance.

Testable Predictions

1. Overexpression of Humanin in cardiac progenitor cells will increase mt‑Keima flux that is sensitive to BNIP3L/NIX or FUNDC1 knockdown but resistant to PINK1 or Parkin loss.
2. Humanin treatment will reduce phospho‑Drp1‑Ser616 levels and increase phospho‑Drp

Hypothesis

Lipid peroxidation adducts on mitochondrial proteins do more than indiscriminately damage function; they act as redox‑sensitive switches that alter the conformation of mitophagy receptors (BNIP3, FUNDC1, PGAM5) and thereby modulate their ability to recruit the autophagy machinery. In strains that accumulate adducts (e.g., C57BL/6), modification of specific lysine residues on these receptors promotes exposure of LC3‑interacting region (LIR) motifs, paradoxically enhancing mitophagy early but leading to receptor saturation and impaired clearance with age. In resistant strains (e.g., DBA/2), lower adduct burden or higher activity of aldehyde‑dehydratase enzymes (ALDH2, SIRT3) prevents this conformational shift, preserving receptor flexibility and sustaining mitophagic flux. Thus, the strain‑dependent trajectory of mitochondrial aging hinges on whether adduct accumulation drives a productive‑to‑non‑productive switch in mitophagy signaling.

Mechanistic Reasoning

1. Adduct‑induced conformational change – HNE/MDA form Michael‑addition adducts on lysine side chains, adding bulk and altering local charge. Structural modeling of BNIP3’s transmembrane domain predicts that modification of Lys‑27 and Lys‑31 destabilizes the α‑helix, exposing a buried LIR motif (WxxL). Similar sites exist in FUNDC1 (Lys‑49) and PGAM5 (Lys‑112).
2. Strain‑specific detoxification – C57BL/6 mice show lower basal ALDH2 activity and reduced SIRT3 deacetylase levels compared with DBA/2, as reported in proteomic surveys of liver mitochondria[2]. Consequently, adducts persist longer, increasi

Hypothesis

Lactonifactor spp. act as a keystone bacterium that enables daidzein‑to‑equol conversion by producing lactate and acetate that feed butyrate‑generating taxa such as Eubacterium coprostanoligenes and Coprococcus. In young adults with high microbial diversity, Lactonifactor abundance supports a cooperative network that channels carbon flux toward equol synthesis. With aging, Lactonifactor declines, disrupting this cross‑feeding and shifting the community toward pro‑inflammatory taxa, thereby lowering equol‑producer prevalence despite adequate daidzein intake.

Testable predictions

1. Cross‑sectional correlation – In a cohort of adults aged 20‑90, fecal Lactonifactor relative abundance will be positively associated with equol‑producer status (binary) and with urinary equol/daidzein ratio, independent of total daidzein intake.
2. Age interaction – The slope of the Lactonifactor–equol relationship will weaken after age 65, reflecting a threshold where Lactonifactor loss outweighs substrate availability.
3. Prebiotic intervention – Administration of a galactooligosaccharide (GOS) supplement known to stimulate Lactonifactor growth will increase its abundance by ≥1.5‑log units within 4 weeks and convert ≥30% of baseline non‑producers to equol producers in participants >65 y.
4. Metabolite flux – In vitro co‑cultures of Lactonifactor strain with E. coprostanoligenes will show elevated lactate consumption and increased equol yields compared with monocultures, demonstrating a cross‑feeding mechanism.

Novel mechanistic reasoning

Unlike Slac

Hypothesis

Long‑term pharmacological silencing of nociceptive input attenuates activity‑dependent calcium signaling in sensory neurons, which reduces downstream activation of CREB/ATF2 transcription factors that drive expression of chondroitin‑6‑sulfotransferase (CHST11, C6ST). The resulting decline in C6‑sulfation shifts the chondroitin sulfate C6S:C4S ratio toward a pro‑aging, osteoarthritis‑associated pattern, exacerbating extracellular matrix (ECM) fragility and accelerating biological aging.

Mechanistic Rationale

1. Nociceptor activation (via TRPV1, Nav1.8) generates Ca2+ influx that stimulates calcium‑dependent kinases (CaMKII, MAPK) leading to phosphorylation of CREB and ATF2 1.
2. CREB/ATF2 bind promoter regions of CHST11 and other Golgi‑resident sulfotransferases, enhancing their transcription 2.
3. Chronic NSAID or opioid use blunts TRPV1‑mediated Ca2+ spikes and reduces substance P/CGRP release, dampening these signaling cascades 3.
4. Lower CHST11 activity decreases C6‑sulfation of newly synthesized chondroitin sulfate, while C4‑sulfotransferase (CHST3) remains relatively unchanged, producing a falling C6S:C4S ratio observed in ageing synovial fluid and intervertebral discs 4 5.
5. Altered sulfation impairs ECM water retention, increases susceptibility to proteolytic cleavage, and promotes low‑grade inflammation, creating a f

Ferroptosis‑based senolytics not only eliminate senescent cells but also generate oxidized lipid mediators that activate NRF2 in surrounding immune cells, thereby dampening SASP‑driven chronic inflammation and restoring endogenous T‑helper‑cell clearance of senescent debris.

Mechanistic Rationale

Senescent cells accumulate labile iron and polyunsaturated fatty acids, making them prone to ferroptosis when exposed to lipid‑peroxidation inducers such as naturally occurring PUFA‑derived compounds Ferroptosis‑based senolytics. The resulting lipid‑peroxidation products include specific oxidized phospholipids (e.g., POVPC, PGPC) that can act as electrophilic signaling molecules. These molecules modify KEAP1 cysteines, leading to NRF2 stabilization and transcription of antioxidant genes in neighboring macrophages and T cells. NRF2 activation has been shown to suppress NF‑κB‑dependent SASP components such as IL‑6 and TNF‑α SASP regulation via mitochondrial dysfunction. Moreover, NRF2‑driven expression of HO‑1 and SOD2 promotes a macrophage phenotype skewed toward tissue repair and enhances the capacity of CD4+ T helper cells to recognize and clear senescent cells via increased perforin/granzyme release T‑cell‑mediated senescent cell clearance.

Experimental Design

1. Model – Use aged mice with experimentally induced osteoarthritis (OA) in the knee joint, a setting

Background

Secondary hemophagocytic lymphohistiocytosis (sHLH) complicates 12–17% of adult-onset Still disease (AOSD) episodes and carries mortality exceeding 40% when recognition is delayed beyond 72 hours of fulminant cytokine storm. Current diagnostic reliance on the HScore requires advanced laboratory parameters (fibrinogen, ferritin, triglycerides, cytopenias) that only become abnormal after macrophage activation has already reached a self-amplifying cascade. Earlier biomarkers capturing the upstream innate immune priming phase could enable pre-emptive therapeutic intervention.

CLEC5A (C-type lectin domain family 5, member A; also MDL-1) is a myeloid pattern recognition receptor whose engagement triggers DAP12-Syk signaling, amplifying NLRP3 inflammasome assembly and driving IL-1β/IL-18 hypersecretion — the precise cytokine axis central to AOSD pathogenesis. Its soluble ectodomain (sCLEC5A) is shed by ADAM10/ADAM17-mediated proteolysis during sustained myeloid activation.

Simultaneously, neutrophil mitochondrial membrane potential (ΔΨm) collapse — measurable by JC-1 or TMRE flow cytometry on routine blood draws — reflects mitochondrial stress-driven NETosis and mitochondrial DNA (mtDNA) release, which further amplifies cGAS-STING and NLRP3-mediated inflammation, feeding the hemophagocytic loop.

Hypothesis

We hypothesize that the composite trajectory of:

1. Rising serum sCLEC5A (reflecting escalating myeloid DAP12-Syk priming), combined with
2. Declining neutrophil ΔΨm index (reflecting mitochondrial stress-driven NETosis priming)

identifies patients

Hypothalamic Menin expression in VMH SF-1 neurons drives circadian NAD+ biosynthesis by activating Nampt transcription, thereby linking SCN timing to systemic SIRT1 activity. When Menin declines with age, Nampt expression falls, reducing NAD+ and SIRT1 deacetylase activity, which leads to hyperacetylation of core clock proteins (BMAL1, PER2) and weakens SCN neuronal rhythms. This circadian dampening further suppresses Menin via diminished CREB‑mediated transcription in VMH, creating a vicious cycle that accelerates multiple hallmarks of aging including genomic instability, inflammation, and proteostatic loss. We'll predict that restoring NAD+ with timed nicotinamide riboside (NR) administration will rescue Menin expression, re‑synchronize central‑peripheral clocks, and ameliorate aging phenotypes in aged mice. It's known that Menin also regulates D-serine metabolism and neuroinflammatory pathways[1]. The hypothesis is falsifiable: if NAD+ repletion normalizes systemic NAD+ and SIRT1 activity but fails to increase Menin levels or restore clock gene rhythmicity in VMH, the proposed upstream controller model is invalid. To test, we'll measure Menin protein, Nampt mRNA, NAD+ concentrations, SIRT1 activity, and clock gene expression (Bmal1, Clock, Per2, Cry1) in VMH and liver of young, old, and old + NR mice under constant darkness, alongside behavioral rhythms and senescence markers (p16, γH2AX). A significant interaction where NR improves Menin and clock metrics only in old mice would support the hierarchical model; absence of such effects would refute it.[1](https://pmc.ncbi.

Hypothesis

Mitochondrial-derived peptides (MDPs) such as MOTS-c and SHLP2 do not only improve mitochondrial bioenergetics; they act as retrograde signals that directly modulate the activity of the nuclear DNA demethylase TET2, thereby restoring heterochromatin at retrotransposon loci and reducing nuclear genome instability driven by mtDNA heteroplasmy.

Mechanistic Rationale

• mtDNA deletions and point mutations increase ROS and alter NAD+/NADH ratios, which impair TET2 Fe(II)-dependent dioxygenase activity, leading to localized DNA hypermethylation and loss of heterochromatin marks (H3K9me3) at LINE‑1 and SINE elements.
• Reduced TET2 activity compromises the recruitment of SETDB1 and TRIM28, allowing retrotransposon transcription, reverse transcription, and new insertions that further destabilize the nuclear genome—a process observed in aged tissues and accelerated in mtDNA mutator mice.
• MDPs can cross the inner mitochondrial membrane and reach the cytosol, where they bind to mitochondrial‑derived vesicles that fuse with the nuclear envelope, delivering the peptide to nucleoplasmic spaces.
• Once in the nucleus, MOTS-c (or SHLP2) allosterically enhances TET2 catalytic efficiency by stabilizing its interaction with IDAX/Wt1 co‑factors, thereby increasing 5‑hmC deposition at retrotransposon promoters and re‑establishing a repressive chromatin state.
• This epigenetic rescue reduces retrotransposon-derived DNA damage (γH2AX foci) and breaks the vicious cycle whereby nuclear genome stress further compromises mitochondrial function via p53‑mediated repression of PGC‑1

Hypothesis

We hypothesize that increasing nuclear NAD+ synthesis specifically through overexpression of the rate‑limiting salvage enzyme NAMPT will selectively boost SIRT6 deacetylase activity, thereby enhancing autophagic clearance of damaged mitochondria and extending male lifespan more effectively than global NAD+ supplementation.

Mechanistic Basis

SIRT6 is an NAD+-dependent deacetylase that regulates DNA repair, metabolism, inflammation, and autophagy (2, 3). Its activity depends on local NAD+ concentration, which can differ between cytosol, nucleus, and mitochondria. While NMN raises the total cellular NAD+ pool (4), it does not guarantee enrichment in the nucleus where SIRT6 predominantly functions (5).

Male mice exhibit higher basal expression of testicular NAMPT, contributing to a male‑biased NAD+ salvage flux that preferentially fuels nuclear SIRT6 (6). This sex‑specific advantage may explain why SIRT6 overexpression yields stronger lifespan effects in males (1).

We propose that forced nuclear targeting of NAMPT (e.g., NLS‑NAMPT) will raise nuclear NAD+ without altering cytosolic levels, thereby activating SIRT6‑driven deace

Hypothesis

Clearing senescent cells with senolytics restores circadian amplitude and phase coherence by reducing SASP-driven CD38 activity, thereby increasing NAD+ levels and SIRT1-mediated deacetylation of BMAL1/CLOCK complexes.

Mechanistic Rationale

Senescent cells secrete a proinflammatory milieu (SASP) that includes IL-6 and PAI-1, which upregulate CD38 expression on neighboring cells[4]. CD38 hydrolyzes NAD+, lowering the pool available for SIRT1 deacetylase activity. SIRT1 directly deacetylates BMAL1, promoting its transcriptional activity and stabilizing the core clock feedback loop[1]. When NAD+ declines, SIRT1 activity falls, leading to hyperacetylated BMAL1, reduced DNA repair capacity, and weakened circadian oscillations[2]. Senolytic removal of senescent cells diminishes SASP, decreasing CD38 expression and preserving NAD+. The resulting NAD+ surplus reactivates SIRT1, which then deacetylates BMAL1, enhancing its binding to E-box elements and driving robust transcription of Per, Cry, and clock-controlled genes. This creates a positive feedback loop where improved clock function further limits senescence by boosting DNA repair and antioxidative defenses.

Experimental Design

Model: 20‑month‑old C57BL/6J mice treated with the senolytic combination dasatinib + quercetin (D+Q) or vehicle control for 12 weeks (n=15 per group). Readouts:

• In vivo circadian monitoring: wheel‑running activity and core body temperature telemetry to assess period, amplitude, and phase stability.
• Ex vivo bioluminescence: PER2::LUC reporter rhythms harvested from suprac

Hypothesis

Biomarker‑triggered intermittent dasatinib + quercetin (D+Q) dosing, initiated when circulating senescence‑associated extracellular vesicle (EV) miRNAs (miR‑146a, miR‑21, let‑7a) exceed a validated threshold, will achieve greater senescent cell clearance, lower inflammatory burden, and attenuate rebound senescence compared with a standard every‑2‑weeks fixed schedule.

Rationale

• D+Q eliminates senescent cells by simultaneously targeting tyrosine‑kinase–dependent and BCL‑2‑family‑dependent anti‑apoptotic pathways [1].
• Intermittent dosing already shows lifespan and functional benefits [2, 3] but relies on arbitrary calendars that ignore individual variation in senescent cell accumulation.
• Senescent cells alter EV cargo, enriching specific miRNAs (miR‑146a, miR‑21, let‑7a) that mirror SASP intensity [7]. These EVs are readily detectable in plasma, offering a non‑invasive readout of senescence load.
• We posit that SASP‑derived miRNAs not only reflect but also feed back to promote paracrine senescence in neighboring cells; thus, clearing senescent cells when their EV‑miRNA signal peaks should interrupt this feed‑forward loop, reducing the emergence of new senescence (the “rebound” concern).

Novel Mechanistic Insight

1. EV‑miRNA as a rheostat – High circulating miR‑146a/miR‑21/let‑7a indicates a tissue microenvironment where SASP‑mediated NF‑κB activation is sustaining senescence

Hypothesis

Centrosome amplification in aged somatic cells is not merely a by‑product of damage but an active signal that modulates the germline stem cell niche to limit reproductive output, thereby enforcing generational turnover. According to this view, supernumerary centrosomes trigger a p53‑dependent senescence program that releases a specific subset of senescence‑associated secretory phenotype (SASP) factors—particularly IGF‑binding proteins and Wnt antagonists—into the circulation. These factors travel to the gonad where they suppress germline stem cell proliferation, reducing fecundity in older individuals. Evolution would retain this mechanism because it speeds up allele turnover and enhances population adaptability without requiring lethal pathology.

Mechanistic Reasoning

1. Centrosome‑p53‑SASP link – In late‑passage fibroblasts, loss of γ‑tubulin and pericentrin leads to centrosome fragmentation, which recruits p53 to the amplified centrosomes 6. p53 then transcriptionally activates a restricted SASP profile enriched for IGFBP‑5 and SFRP2, proteins known to inhibit germline stem cell activity 3.

2. Systemic communication – Extracellular vesicles shed from senescent centrosome‑amplified cells carry these SASP proteins to the gonadal niche, where they activate downstream pathways (e.g., reduced AKT signaling in germline stem cells) that induce quiescence or apoptosis.

3. Feedback to somatic aging – Reduced germline signaling lowers circulating gona

Hypothesis

Strong photoperiodic entrainment of the circadian clock drives seasonal reproductive cycles via melatonin signaling, which imposes an antagonistically pleiotropic trade‑off: it boosts early‑life fertility and survival in favorable seasons while accelerating late‑life somatic deterioration. Individuals with genetically attenuated melatonin‑receptor signaling will show delayed onset of age‑related pathology but reduced seasonal reproductive output, a pattern predictable from the disposable soma theory.

Mechanistic Basis

Melatonin, secreted nocturnally in proportion to night length, binds MT1/MT2 receptors in the suprachiasmatic nucleus and peripheral tissues. In mouse liver and muscle, MT1 activation suppresses AMPK and elevates mTORC1 activity, shifting cellular metabolism toward anabolism and away from autophagy—a shift that supports rapid growth and gonadal maturation in youth but promotes accumulation of damaged proteins and senescent cells later in life [1]. This mirrors classic antagonistic pleiotropy: alleles that enhance MT1 signaling increase early fecundity (more litters per breeding season) yet elevate markers of cellular senescence (p16^INK4a^, SASP) after midlife.

Recent work shows that Per2 mutants exhibit altered melatonin rhythms and extended lifespan under constant darkness, suggesting that core clock components modulate the hormone’s seasonal signal [2]. Moreover, human GWAS link variants in MTNR1B to both higher birth rates and ea

...